>latest-news

Second Meeting Of IHR Emergency Committee Confirms Mpox As Public Health Emergency

WHO confirms mpox as a PHEIC, urging stronger global collaboration, resource mobilisation, and equitable access to vaccines and treatments.

Breaking News

  • Nov 29, 2024

  • Simantini Singh Deo

Second Meeting Of IHR Emergency Committee Confirms Mpox As Public Health Emergency

The World Health Organisation (WHO) has released the report of the second International Health Regulations (IHR) Emergency Committee meeting on the 2024 mpox outbreak. November 22, 2024, the conference reviewed the ongoing global response to mpox, particularly cases linked to the monkeypox virus clade Ib. While acknowledging progress in controlling the spread, the Committee highlighted concerns over the rising number of cases, broader geographic distribution, and operational challenges that require stronger national commitments and international collaboration. Based on their findings, the Committee recommended that mpox continue to meet the criteria for a Public Health Emergency of International Concern (PHEIC).


In agreement with the Committee, the WHO Director-General confirmed continuing the PHEIC designation for mpox. Revised temporary recommendations were issued to strengthen global efforts to manage the outbreak. The Director-General expressed gratitude to the Committee members and advisors for their contributions and urged sustained efforts to mitigate the spread of the disease. The recommendations emphasise cohesive international cooperation and resource mobilisation to combat mpox effectively.


The meeting included participation from 16 Committee members and advisors and representatives from five invited nations, Burundi, the Democratic Republic of the Congo, Kenya, Rwanda, and Uganda. WHO officials emphasised the evolving complexity of the mpox situation, citing the need for robust measures to prevent wider outbreaks, especially in countries with limited cases. Collaborative initiatives, such as the Access and Allocation Mechanism, have been developed to ensure equitable distribution of vaccines, treatments, and diagnostics, focusing on nations with constrained resources.


WHO representatives also highlighted challenges, including competing health priorities and limited resources, which necessitate increased political and financial commitments from governments. The meeting reiterated the importance of integrated, targeted local interventions and called for intensified international support. Participants were reminded of their ethical responsibilities, including the confidentiality of discussions and disclosure of potential conflicts of interest, ensuring transparency and accountability in decision-making.

Ad
Advertisement